Treatment of liver ischemia-reperfusion injury by limiting thrombospondin-1/CD47 signaling

Surgery

Volumn 144, Issue 5, 2008, Pages 752-761

  Isenberg, Jeff S ^a   Maxhimer, Justin B ^a   Powers, Perlita ^b   Tsokos, Maria ^a   Frazier, William A ^c   Roberts, David D ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD47 ANTIGEN; LIVER ENZYME; THROMBOSPONDIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOLOGICAL PHENOMENA AND FUNCTIONS CONCERNING ORGAN SYSTEMS; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; HISTOLOGY; IMMUNOHISTOLOGY; LASER DOPPLER FLOWMETRY; LIVER; LIVER ISCHEMIA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPERFUSION INJURY; SURVIVAL; TISSUE PERFUSION; TRANSPLANTATION; WILD TYPE;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS, CD47; FEMALE; IMMUNOLOGIC FACTORS; LIVER; MALE; MICE; MICE, INBRED C57BL; RECOVERY OF FUNCTION; REPERFUSION INJURY; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1;

EID: 53949099844     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2008.07.009     Document Type: Article

References (47)

1. Kupiec-Weglinski J.W., and Busuttil R.W. Ischemia and reperfusion injury in liver transplantation. Transplant Proc 37 (2005) 1653-1656
2. Kim Y.I. Ischemia-reperfusion injury of the human liver during hepatic resection. J Hepatobiliary Pancreat Surg 10 (2003) 195-199
3. Arii S., Teramoto K., and Kawamura T. Current progress in the understanding of and therapeutic strategies for ischemia and reperfusion injury of the liver. J Hepatobiliary Pancreat Surg 10 (2003) 189-194
4. Fondevila C., Busuttil R.W., and Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury-a fresh look. Exp Mol Pathol 74 (2003) 86-93
5. Yin H., Chao L., and Chao J. Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion. Life Sci 82 (2008) 156-165
6. Liu X., Huang Y., Pokreisz P., et al. Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion. J Am Coll Cardiol 50 (2007) 808-817
7. Iwase H., Robin E., Guzy R.D., et al. Nitric oxide during ischemia attenuates oxidant stress and cell death during ischemia and reperfusion in cardiomyocytes. Free Radic Biol Med 43 (2007) 590-599
8. Hiramatsu T., Forbess J.M., Miura T., and Mayer Jr. J.E. Effect of L-arginine cardioplegia on recovery of neonatal lamb hearts after 2 hours of cold ischemia. Ann Thorac Surg 60 (1995) 1187-1192
9. Katsumi H., Nishikawa M., Yamashita F., and Hashida M. Prevention of hepatic ischemia/reperfusion injury by prolonged delivery of nitric oxide to the circulating blood in mice. Transplantation 85 (2008) 264-269
10. Tuncer M.C., Ozturk H., Buyukbayram H., and Ozturk H. Interaction of L-arginine-methyl ester and Sonic hedgehog in liver ischemia-reperfusion injury in the rats. World J Gastroenterol 13 (2007) 3841-3846
11. Fotiadis C., Adamis S., Misiakos E.P., et al. The prophylactic effect of L-arginine in acute ischaemic colitis in a rat model of ischaemia/reperfusion injury. Acta Chir Belg 107 (2007) 192-200
12. Rogers III H., Zibari G.B., Roberts J., et al. Nitric oxide attenuates ischaemia-reperfusion (I/R) injury in the diabetic liver. Clin Transplant 18 Suppl 12 (2004) 7-11
13. Chen T., Zamora R., Zuckerbraun B., and Billiar T.R. Role of nitric oxide in liver injury. Curr Mol Med 3 (2003) 519-526
14. Isenberg J.S., Ridnour L.A., Perruccio E.M., et al. Thrombospondin-1 inhibits endothelial cell responses to nitric oxide in a cGMP-dependent manner. Proc Natl Acad Sci U S A 102 (2005) 13141-13146
15. Isenberg J.S., Wink D.A., and Roberts D.D. Thrombospondin-1 antagonizes nitric oxide-stimulated vascular smooth muscle cell responses. Cardiovasc Res 71 (2006) 785-793
16. Isenberg J.S., Romeo M.J., Yu C., et al. Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood 111 (2008) 613-623
17. Isenberg J.S., Ridnour L.A., Dimitry J., et al. CD47 is necessary for inhibition of nitric oxide-stimulated vascular cell responses by thrombospondin-1. J Biol Chem 281 (2006) 26069-26080
18. Isenberg J.S., Hyodo F., Matsumoto K., et al. Thrombospondin-1 limits ischemic tissue survival by inhibiting nitric oxide-mediated vascular smooth muscle relaxation. Blood 109 (2007) 1945-1952
19. Isenberg J.S., Romeo M.J., Abu-Asab M., et al. Increasing survival of ischemic tissue by targeting CD47. Circ Res 100 (2007) 712-720
20. Isenberg J.S., Hyodo F., Pappan L.K., et al. Blocking thrombospondin-1/CD47 signaling alleviates deleterious effects of aging on tissue responses to ischemia. Arterioscler Thromb Vasc Biol 27 (2007) 2582-2588
21. Eum H.A., Cha Y.N., and Lee S.M. Necrosis and apoptosis: sequence of liver damage following reperfusion after 60 min ischemia in rats. Biochem Biophys Res Commun 358 (2007) 500-505
22. Ghetie V., Popov S., Borvak J., et al. Increasing the serum persistence of an IgG fragment by random mutagenesis. Nat Biotechnol 15 (1997) 637-640
23. Isenberg J.S., Pappan L.K., Romeo M.J., et al. Blockade of thrombospondin-1-CD47 interactions prevents necrosis of full thickness skin grafts. Ann Surg 247 (2008) 180-190
24. Lagadec P., Dejoux O., Ticchioni M., et al. Involvement of a CD47-dependent pathway in platelet adhesion on inflamed vascular endothelium under flow. Blood 101 (2003) 4836-4843
25. Kunduzova O.R., Escourrou G., Seguelas M.H., et al. Prevention of apoptotic and necrotic cell death, caspase-3 activation, and renal dysfunction by melatonin after ischemia/reperfusion. FASEB J 17 (2003) 872-874
26. Jaeschke H., and Lemasters J.J. Apoptosis versus oncotic necrosis in hepatic ischemia/reperfusion injury. Gastroenterology 125 (2003) 1246-1257
27. Hamacher-Brady A., Brady N.R., and Gottlieb R.A. The interplay between pro-death and pro-survival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 20 (2006) 445-462
28. Khera T.K., Martin J., Riley S.G., et al. Glucose modulates handling of apoptotic cells by mesangial cells: involvement of TGF-beta1. Lab Invest 87 (2007) 690-701
29. Rath G.M., Schneider C., Dedieu S., et al. Thrombospondin-1 C-terminal-derived peptide protects thyroid cells from ceramide-induced apoptosis through the adenylyl cyclase pathway. Int J Biochem Cell Biol 38 (2006) 2219-2228
30. Lamy L., Foussat A., Brown E.J., et al. Interactions between CD47 and thrombospondin reduce inflammation. J Immunol 178 (2007) 5930-5939
31. Cassie S., Masterson M.F., Polukoshko A., et al. Ischemia/reperfusion induces the recruitment of leukocytes from whole blood under flow conditions. Free Radic Biol Med 36 (2004) 1102-1111
32. Lindberg F.P., Bullard D.C., Caver T.E., et al. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice. Science 274 (1996) 795-798
33. Ticchioni M., Raimondi V., Lamy L., et al. Integrin-associated protein (CD47/IAP) contributes to T cell arrest on inflammatory vascular endothelium under flow. FASEB J 15 (2001) 341-350
34. Li Z., Calzada M.J., Sipes J.M., et al. Interactions of thrombospondins with alpha4beta1 integrin and CD47 differentially modulate T cell behavior. J Cell Biol 157 (2002) 509-519
35. Mansfield P.J., and Suchard S.J. Thrombospondin promotes chemotaxis and haptotaxis of human peripheral blood monocytes. J Immunol 153 (1994) 4219-4229
36. Narizhneva N.V., Razorenova O.V., Podrez E.A., et al. Thrombospondin-1 up-regulates expression of cell adhesion molecules and promotes monocyte binding to endothelium. FASEB J 19 (2005) 1158-1160
37. Cooper D., Lindberg F.P., Gamble J.R., et al. Transendothelial migration of neutrophils involves integrin-associated protein (CD47). Proc Natl Acad Sci U S A 92 (1995) 3978-3982
38. Liu Y., Merlin D., Burst S.L., et al. The role of CD47 in neutrophil transmigration. Increased rate of migration correlates with increased cell surface expression of CD47. J Biol Chem 276 (2001) 40156-40166
39. Friedman G.B., Taylor C.T., Parkos C.A., and Colgan S.P. Epithelial permeability induced by neutrophil transmigration is potentiated by hypoxia: role of intracellular cAMP. J Cell Physiol 176 (1998) 76-84
40. Grimbert P., Bouguermouh S., Baba N., et al. Thrombospondin/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25- T cells in response to inflammation. J Immunol 177 (2006) 3534-3541
41. Lin T.N., Kim G.M., Chen J.J., et al. Differential regulation of thrombospondin-1 and thrombospondin-2 after focal cerebral ischemia/reperfusion. Stroke 34 (2003) 177-186
42. Sezaki S., Hirohata S., Iwabu A., et al. Thrombospondin-1 is induced in rat myocardial infarction and its induction is accelerated by ischemia/reperfusion. Exp Biol Med (Maywood) 230 (2005) 621-630
43. Thakar C.V., Zahedi K., Revelo M.P., et al. Identification of thrombospondin 1 (TSP-1) as a novel mediator of cell injury in kidney ischemia. J Clin Invest 115 (2005) 3451-3459
44. Chan C.K., Pham L.N., Zhou J., et al. Differential expression of pro- and antiangiogenic factors in mouse strain-dependent hypoxia-induced retinal neovascularization. Lab Invest 85 (2005) 721-733
45. Distler J.H., Jungel A., Pileckyte M., et al. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis. Arthritis Rheum 56 (2007) 4203-4215
46. Ridnour L.A., Isenberg J.S., Espey M.G., et al. Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc Natl Acad Sci U S A 102 (2005) 13147-13152
47. Murphy-Ullrich J.E., and Poczatek M. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology. Cytokine Growth Factor Rev 11 (2000) 59-69